Given previous in vitro studies demonstrated that S-75 blocked α1A- and α1B-adrenoceptors, and these receptors can contribute to the development of cardiac arrhythmias induced by catecholamines, we aimed to evaluate the compound’s antiarrhythmic activity. This evidence concerns the gene SERPINA1 and chronic obstructive pulmonary disease.